Abstracts

ORAL PRESENTATIONS S1 O-01: Clinical Features Significantly Associated with Central Line-associated Blood Stream Infection (Clabsi) in Children on Home Parenteral Nutrition (PN) S1 O-02: Elastography for the Diagnosis and Graduation of Liver Disease in Patients with Long Term Parenteral Nutrition S2 O-03: A Monocentric Single-arm Study on Long-term Safety and Efficacy of Teduglutide in SBS Pediatric Patients on Long-term Home-parenteral Nutrition S2 O-04: Iodine Status in Children with Intestinal Failure S3 O-05: Ghrelin in Children with Intestinal Failure Receiving Long-term Parenteral Nutrition S3 O-06: Experimental Assessment of Multivisceral Graft Damage in Controlled Donation after Circulatory Death S4 O-07: Current International Intestinal Transplant Registry Data is Insufficient for Immunologic Risk Assessments S4 O-08: Small Bowel Dilatation in Pediatric Intestinal Rehabilitation Patients: Surgical Aspects and Proposal of a Treatment Algorithm S5 O-09: Intestinal Organ Donation: Donor Criteria, Screening, and Utilization S5 O-10: Outcomes of Children with Intestinal Failure Secondary to Ultrashort Bowel Syndrome S6 O-11: Developing a Validated Knowledge Survey to Evaluate Clinician Expertise in Chronic Intestinal Failure S6 O-12: Non Convectional Vascular Accesses for Treatment of Total Superior Vena Cava Syndrome Occlusion in Patients with Type Iii Intestinal Failure S7 O-13: Single-center Experience of Over 300 Adult and Pediatric Intestinal Transplants S7 O-14: Portal Hypertensive Complications after Pediatric Combined Liver-intestine Transplantation from Late Vascular Compromise of Native Portacaval Shunt: Clinical Presentation and Management S8 O-15: The Noticeable Diversity in Phenotype of ACTG2-Related Disorders – A Report of 4 Cases and Systematic Review of the Literature S8 O-16: The Primary and Adjunctive Benefit of Serial Transverse Enteroplasty on Short Gut Patients with Gut Failure S9 O-17: A Promising Technique for Mechanical Intestinal Lengthening Using Biodegradable Device S9 O-18: Value of Endoscopy Surveillance in the First Year Following Paediatric Intestinal Transplant S10 O-19: Intestinal Re-Transplantation. Indications and Outcomes S10 O-20: Use of Minimum Care Standards & Wireless Pumps in Paediatric Home IVN/PN Patients to Mitigate Child Protection Concerns: Case Report S11 O-21: Using Virtual Technology to Preserve the Lifespan of Central Venous Access Devices S11 O-22: The Effect of the COVID-19 Pandemic in Intestinal Rehabilitation and Transplant Patients, Initial Results of an International Survey S12 O-23: Pediatric Home Parenteral Nutrition in France: A Six Years National Survey S12 O-24: A Transition and Independence Pathway Designed for Children and Young People with Intestinal Failure S13 O-25: A Single-Center, Detailed Report of Malignancies Following Intestinal Transplantation S13 O-26: Pre- and Peri-transplant Factors Impacting Frequency of Endoscopy after Intestinal Transplantation S14 O-27: Role of Surveillance Biopsy Frequency Post Intestine Transplant: A Tertiary Care Experience S14 O-28: Comprehensive Gut Rehabilitation and Transplantation for Gut Failure in Crohn’s Disease: Evolving Role of Serial Transverse Enteroplasty S15 O-29: Medical Predictors of Social-emotional and Adaptive Functioning in School-Age Pediatric Intestinal Failure S15 O-30: Stoma-output Reinfusion Device for Ileostomy Patients: A Feasibility Study S16 O-31: Growth and Fat Mass, But Not Fat-free Mass, are Compromised in Infants with Parenteral Nutrition Need after Neonatal Intestinal Surgery S16 O-32: RNA Sequencing (RNAseq) Tissue Analysis Can Provide Early Warning Signals for Potential Intestinal Transplant Complications S17 O-33: Growth and Geographic Reach of the LIFT-ECHO Program to Disseminate Knowledge in Intestinal Failure S18 O-34: Cost-effectiveness of Ethanol Lock Prophylaxis to Prevent Central Line-associated Bloodstream Infections in Children with Intestinal Failure in the United States S18 O-35: Enhanced Virtual Cross Match in Intestinal Transplantation: Association with Outcomes and Application in Practice S19 O-36: Intestinal Graft Quality after Norepinephrine and Dopamine Management in an Experimental Brain Dead Model S19 O-37: Immune Profiling of γδ T Cells Locally and Systemically after Human Intestinal Transplantation Reveals Unique Innate and Adaptive Features S20 O-38: Proof-of-principle Investigation for Organoid-based Hybrid Intestine in a Rat Short Bowel Syndrome Model S20 O-39: Comparison of the Effects of Normothermic Machine Perfusion and Cold Storage Preservation on Porcine Intestinal Allograft Regenerative Potential and Viability S21 O-40: Single-Cell Immune Profiling of Human Intestinal Allografts Reveals Differential Contributions of HvG T-cell Clones in Quiescent vs Chronically Rejecting Allografts S22 O-41: Intravenous Polyethylene Glycol Attenuates Intestinal Ischemia-reperfusion Injury in a Rat Model S22 O-42: Pediatric Composite Liver-intestine Transplantation with Native Splenopancreatic Preservation: Immunologic Complications and Long-term Outcomes S23 O-43: Child Self-reported Quality of Life in Pediatric Intestinal Failure S23 O-44: Successful intestinal transplant recipients have comparable return to work rates as other solid organ transplants S24 O-45: Stress, Anxiety and Health-Related Quality of Life in Caregivers of Children with Intestinal Failure on Parenteral Nutrition S24 O-46: Cost-utility of Kitelock in Preventing Central Line-associated Blood Stream Infections in Children with Intestinal Failure: A Markov Model S25 O-47: Health-Related Quality of Life of Children on Home Parenteral Nutrition S26 O-48: Use of Blenderized Formulas in Intestinal Failure and After Intestinal Transplantation S27 O-49: The First Five Years of the New Zealand National Intestinal Failure & Rehabilitation Service S27 O-50: 10 Years of Intestinal Transplant in Australia S28 O-51: Intestinal Rehabilitation Centers in Latin America: How Are We? Posters of Excellence S29 PE-1: “Line Care Governs Our World”: Understanding the Lived Experience of Caregivers of Children with Intestinal Failure on Long-term Parenteral Nutrition S29 PE-2: Dynamic Reconstitution of Recipient Resident Memory T Cell Repertoire after Human Intestinal Transplantation S30 PE-3: Surveillance Practices of Pediatric Intestinal Failure Patients By North American Intestinal Rehabilitation Programs S31 PE-4: Clinical Data in Short Bowel Syndrome (SBS): A Data Driven Approach S31 PE-5: First Hematopoietic Stem Cell Transplantation as Prevention of Rejection in a Multivisceral Transplant S32 PE-6: Role of APC Subsets in Rejection and Graft-Versus-Host-Disease in Intestinal Transplantation S32 PE-7: Glepaglutide Pharmacokinetic Profile after Single Subcutaneous Injection in Human Subjects with Varying Degrees of Renal Function S33 PE-8: Relation Between Surgical Procedures, Chronic Intestinal Failure and Dependency on Parenteral Support S33 PE-9: Validation of Sodium Concentration in Urine By POCT: Feasibility of the Medimate in Patients with an Ileostomy S34 PE-10: Long Term Outcomes of Intestinal Allografts Transplanted Following Length Reduction (LR) S35 PE-11: Pediatric Multivisceral Transplant for Portomesenteric Thrombosis and Hostile Abdomen S35 PE-12: Role of B-cell Subsets in Allograft Rejection in Intestinal Transplantation S36 PE-13: Ulcerative Enteritis Succesfully Treated with Tocilizumab in Two Multivisceral Recipients: Personalized Therapy Based in Intragraft Gene Expression S36 PE-14: Brain Death Donor Model for Intestinal Injury Studies in Pigs S37 PE-15: REG3α May Be a Novel Marker for Acute Cellular Rejection after Adult Isolated Intestinal Transplantation S37 PE-16: Pharmacokinetics and Pharmacodynamics of Long-Acting GLP-2 Analogue Glepaglutide after Once-weekly Dosing in Adult Healthy Subjects S38 PE-17: Blockage of PD-L1 Expression in Intestinal Graft Accelerates Allogeneic Immune Response in Mice S38 PE-18: Comparison of the Incidence and Type of Rejection Between Patients with Tacrolimus and Sirolimus after Intestinal Transplantation S39 PE-19: Clinically Applicable PEG-based Intraluminal Preservation of Human Small Intestines Does Not Reduce Histological Damage Compared to Standard Vascular Flush S39 PE-20: Development of a Consensus Parenteral Nutrition Weaning Algorithm for Paediatric Patients with Short-bowel Syndrome Responding to Teduglutide Therapy S40 PE-21: Assessment of Moderate and Severe Intestinal Failure Associated Liver Disease. Clinical, Analytical and Histological Correlation S41 PE-22: Variation of Plasma Citrulline Over Time is a Predictive Factor of Weaning Off Parenteral Nutrition in Children with Neonatal SBS S41 PE-23: Reversal of Treatment-refractory Malabsorption after Resection of Jejunal Diverticulosis: A Case Series S42 PE-24: Intestinal Failure Associated Liver Disease and Acute on Chronic Liver Failure: an Entity of Increased Mortality S42 PE-25: Significant Improvement in Catheter Related Infections, Hospitalization Duration and Self-care after the Implementation of a Multidisciplinary Approach in Intestinal Failure S43 PE-26: Normothermic Machine Perfusion of the Full-length Porcine Intestinal Graft: the First Translatable Protocol for Transplantation S43 PE-27: Long-term Nutritional Status in Pediatric Small Bowel Transplantation S44 PE-28: Chyme Reinfusion for Small Bowel Double Enterostomies and Enteroatmospheric Fistulas in Adult Patients: A Systematic Review S44 PE-29: The Impact of Intestinal Failure on Quality of Life Considering Anatomy and Function S45 PE-30: The Prevalence of Cow’s Milk Protein Allergy in Infants with Gastroschisis and Intestinal Failure type 2 and 3 S45 PE-31: Single-centre Experience on Central Venous Catheter-related Complications in Children on Home Parenteral Nutrition S46 PE-32: Improved Graft Survival in Liver-free Visceral Transplantation with Strong Preformed Donor Specific Antibody S46 PE-33: Long-term Nutritional Outcomes of Children Following Intestinal Transplantation POSTER PRESENTATIONS S48 P-01: Rat Model of Intestinal Ischemia-reperfusion Injury: Impact of Anesthetic Method S48 P-02: Implication of NOD2 Polymorphisms in Intestinal Transplantation Recipients S49 P-03: The Small Intestine is Protected by the Presence of Luminal Preservation Solution During Cold Storage in a Brain-dead Rat Model S49 P-04: Monitoring of Tacrolimus Level in an Experimental Model of Intestinal Transplantation S50 P-05: The Effect of Varying Colloid Osmotic Pressure in the Luminal Preservation Solution During the Static Cold Preservation of Rat Intestines S50 P-06: Intra-tissue Immune Response in Pediatric Patients with Short Bowel Syndrome S51 P-07: Segmental Susceptibility of Intestinal Stem Cells to Cold Storage Preservation Injury in a Porcine Model S51 P-08: The Challenge of Electing and Maintaining Immunosuppressive Protocols after Intestinal Transplant. Impact on Freedom from Rejection Survival and Graft Loss S52 P-09: Small Bowel Transplantation at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil S52 P-10: Scoring Criteria for Intestinal Failure Assessment S54 P-11: Epidemiology and Clinical Outcomes of Chronic Intestinal Failure Patients Undergoing Home Parenteral Nutrition, Experience from A Brazilian Intestinal Rehabilitation Center S54 P-12: Sahlgrenska Intestinal Failure and Transplant Centre (SIFT) - A Swedish Experience S55 P-13: Postoperative Weaning Strategies from PN Used in European Multidisciplinary IF Rehabilitation Centers: A Report from the ERNICA if Working Group S55 P-14: Gut Liver Axis in Short Bowel Syndrome S56 P-15: 100 Intestinal and Multivisceral Transplants at a Single UK Centre S56 P-16: RESTORE: A Registry of Adult Patients with Type III Intestinal Failure (III-IF) Due to Short Bowel Syndrome (SBS) in Argentina S57 P-17: Transplant Associated Thrombotic Microangiopathy and Immune Haematological Complications Following Intestine Containing Organ Transplantation: Experience from Over 100 Consecutive Cases S57 P-18: COVID-19 in Small Bowel Transplant Recipients: A Single Center Experience S58 P-19: Intestinal Failure Associated Liver Disease in Paediatric Patients Underwent Intestinal Lengthening Surgery for Short Bowel Syndrome S58 P-20: Thirty Years of Intestinal Transplantation: Unique Outcomes from a Large Single-Center S59 P-21: Achieving Intestinal Sufficiency: The Evolving Experience of a Single Intestinal Failure, Rehabilitation and Transplant Unit S59 P-22: Protective Effect of Liver-inclusive Intestinal Transplantation: A Single Center Analysis S60 P-23: Isolated Liver Transplant as a Rescue in Children with End-stage Intestinal Failure-Associated Liver Disease S60 P-24: Outcome of Children with Intestinal Failure (IF) and Severe Neurological Impairment(NI) Treated with Parenteral Nutrition (PN) at Home S61 P-25: Case Series of Parenteral Nutrition-dependent Children with Thiamine Deficiency from Withholding Intravenous Multivitamin due to Factitious Disorder Imposed on Another S61 P-26: Preoperative Personalised Surgical Planning for Patient Undergoing Spiral Intestinal Lengthening and Tailoring: A Mathematical Approach S62 P-27: Results of Ernica* Survey on Food Introduction in Infants with Short Bowel Syndrome Managed by Specialist Intestinal Failure Rehabilitation Centres S62 P-28: Food Rehabilitation in Paediatric Population with Short Bowel Syndrome S63 P-29: Rapid Progression of Parenteral Nutrition-associated Liver Disease on Liver Biopsies of Pediatric Patients with Short-gut Syndrome: A Case Series S63 P-30: Impact of Antibiotic Stewardship on Gut Microbiome in Short Bowel Syndrome (SBS) Pediatric Patients S64 P-31: Real World Experience and 12 Month Outcomes for Patients Treated with Teduglutide at an Australian Centre S64 P-32: Autologous Gut Reconstruction (AGR), Long Term Management and the Concept of Intestinal Rehabilitation S65 P-33: Introduction of Transient Elastography (FibroScan) in the Evaluation of Intestinal Failure-associated Liver Disease (IFALD) in a Pediatric Intestinal Rehabilitation Unit S65 P-34: The Prevalence of Liver Fibrosis According to Non-invasive Tools in a Pediatric Home Parenteral Nutrition Cohort S66 P-35: Intracardiac Thrombus and Infective Endocarditis in Children with Chronic Intestinal Failure on Long-term Parenteral Nutrition S66 P-36: Use of Intravenous Iron Sucrose in Pediatric Intestinal Failure Patients S67 P-37: Single-Center Experience with Teduglutide in Pediatric Patients with Short Bowel Syndrome Associated Intestinal Failure S68 P-38: Use of Lactase Enzyme for Control of Diarrhea in Patients Breast Fed with Short Bowel Syndrome S68 P-39: Health Care Costs associated with Australian Home Parenteral Nutrition S69 P-40: Management of Intestinal Failure from an Intestinal Rehabilitation Unit in the Middle East S69 P-41: Anti-Plasma Cell Treatment in Refractory Autoimmune Hemolytic Anemia in a Child with Multivisceral Transplant S70 P-42: Experience With Teduglutide of a Single Center in Pediatric Short Bowel Syndrome S70 P-43: Digestive Manifestations of Patients With Genetic Diagnosis of DGAT1 Deficit in a Tertiary Hospital S71 P-44: Prophylactic Anticoagulation in Children Receiving Home Parenteral Nutrition S71 P-45: Quality of Trace Mineral Monitoring and Replacement for Patients on Teduglutide for Short Bowel Syndrome S72 P-46: Gallstones in Children on Long-term Parenteral Nutrition S73 P-47: Chyme Recycling in the Management of Small Bowel Double Enterostomy in Paediatric and Neonatal Populations: A Systematic Review S73 P-48: Temporary Use of High Glucose Infusion Rate and Lipid Minimization to Treat Pediatric Intestinal Failure Patients Severely Malnourished and Cholestatic S74 P-49: Nutritional Characteristics of a High Absorption Oral Diet for Short Bowel Syndrome: Experience of a Brazilian Intestinal Rehabilitation Center S74 P-50: Essential Fatty Acid Status in Children with Intestinal Failure, Dependent on Home Lipid Emulsion S75 P-51: Successful Central Venous Catheter Salvage after Central Line Associated Blood Stream Infections(CLABSI) in Children on Long-term Home Parenteral Nutrition(PN) S75 P-52: Reducing Hours of Parenteral Nutrition Resulting in Hypoglycaemia in Infants with Intestinal Failure: A Case Report S76 P-53: The Impact of Autologous Intestinal Reconstructions in the Management of Ultrashort Bowel Syndrome S76 P-54: Isolated Liver Transplant in Paediatric Intestinal Failure: A Single Centre Review of Nutritional Intake S77 P-55: Intestinal Transplant for Inflammatory Bowel Disease S77 P-56: Preventing Encephalopathy after Isolated Small Bowel Transplantation Through Portal Drainage S78 P-57: The Correlation of Estimated Glomerular Filtration Rate in the Assessment of Renal Function in Patients with CIPO after Intestinal Transplantation S78 P-58: Alemtuzumab for Severe Acute Cellular Rejection (ACR) in Intestinal Transplant (ITx) S79 P-59: Intestinal and Multivisceral Transplantation is an Effective Treatment for Patients with Extensive Neuroendocrine Tumors: A Systematic Literature Review S79 P-60: Single Centre Experience of Paediatric Intestinal Transplantation During the COVID-19 Pandemic: Lessons from Adapting to Pandemic Pressures S81 P-61: Severe Acute Rejection after Intestinal Transplantation Without Liver Graft S81 P-62: A Multicenter Evaluation of the Diagnosis, Management and Outcomes of Adenovirus Enteritis Infection Following Intestine or Multivisceral Transplant S82 P-63: Indications for Liver or Multivisceral Transplantation: A Diffuse Borderline S82 P-64: Experiences with Intestinal Transplantation in a Country Without Home Parenteral Nutrition S83 P-65: Visceral Transplantation for Pediatric Patients with Rare Genetic Syndromes S83 P-66: Adequate Exposure to Tacrolimus with Sublingual Administration S84 P-67: HLA Antibody Monitoring Pre and Post Intestinal Transplant S84 P-68: The Degree of Post-transplant Hypomagnesaemia Seen in Multivisceral Recipients Cannot be Explained Solely by the use of PPI or Immunosuppression S85 P-69: Pediatric Isolated Intestinal Transplant Without an Ostomy S85 P-70: Native Jejunal Conduit for Urinary Diversion in Enbloc Liver-Intestine-Kidney Transplantation for a Patient with Irradiation Enteritis and Cystitis S86 P-71: Pretransplant Donor-Specific Anti-HLA Antibodies Increase Severity of Acute Cellular Rejection and Antibody Mediated Rejection after Intestinal Transplantation S86 P-72: Long-term Functional Results of Hirschsprung Disease after Multivisceral Transplantation S87 P-73: Non-invasive Monitoring of Intestinal Allograft Function S87 P-74: Change in CMV Infection Rates Over Time at a UK Transplant Centre S88 P-75: Living Donor Intestinal Transplantation: A Valuable Strategy to Overcome the Shortage of Pediatric Small Bowel Donors S88 P-76: Isolated Plasma Cell Rich Liver Rejection in Adult Liver, Small Bowel and Pancreas Transplant S89 P-77: Effectiveness of Desensitization Therapy in Pediatric Intestinal Transplant Recipients S89 P-78: Vacuum-assisted Closure (VAC) Therapy Applications in a Paediatric Intestinal Rehabilitation Unit S90 P-79: COVID-19 Presentation in Pediatric Patients with Visceral Transplantation S90 P-80: “Colostrum Supplement and Intestinal Adaptation after Intestinal Surgery and Short Bowel Syndrome: Review of the Literature” S91 P-81: COVID-19 Outcome in an Isolated Intestinal Transplant Recipient S91 P-82: A Case of Refractory Celiac Disease in a Pediatric Patient with Short Bowel Syndrome S92 P-83: Laparoscopic Sleeve Gastrectomy for Obesity after Combined Liver-intestinal Transplantation is Feasible and Safe S93 P-84: Mixed Physiological and Non-physiological Portal Inflow as an Alternative to Multivisceral Transplantation in a Patient with Diffuse Splanchnic Thrombosis S94 P-85: Quality of Life in Patients in Home Parenteral Nutrition in Brazil S94 P-86: Psychosocial and Financial Needs of Caregivers and Families of Children with Chronic Intestinal Failure on Home Parenteral Nutrition S95 P-87: Transition Towards Independent Management for Adolescent Patients with Intestinal Failure: Our Inaugural Experience S95 P-88: Supporting Intestinal Families in the Virtual World During the COVID-19 Pandemic S96 P-89: Non-hematologic Malignancy Following Adult Intestine Transplantation: A Single Center Experience S96 P-90: Catheter Related Infection in Patients with Intestinal Failure Using Home Parenteral Nutrition S97 P-91: The Role of the Social Worker Concerning Intestinal Rehabilitation and Transplantation in a Latin American Center S97 P-92: Psychosocial Complexity in Paediatric Intestinal Failure Pre- and Post-Transplant: A Case-series S98 P-93: Successful Training of Caregivers with Low Socioeconomic Status for Home Parenteral Nutrition in Pediatric Patients with Intestinal Failure S99 P-94: The Need for Social Care Support in Children Pre- and Post-Intestiinal Transplant, a Case Series S99 P-95: Quality of Life Assessment of the Home Parenteral Nutrition Patients in the Waiting List for Intestinal Transplantation in Brazil

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.